世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5203 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の市場動向 ・企業の競争状況、市場シェア ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の種類別市場規模と予測2016-2027（ステント、PTAバルーン） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の北米市場規模2016-2027（アメリカ、カナダ） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Stryker、Balt、TERUMO、MicroPort、Acandis） ・結論

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

Market Analysis and Insights: Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market
The global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Scope and Market Size
ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stent
PTA Balloon

Segment by Application
Hospital
Clinic
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Stryker
Balt
TERUMO
MicroPort
Acandis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Perspective (2016-2027)
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Trends by Regions
2.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industry Dynamic
2.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Trends
2.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers
2.3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
2.3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players by Revenue
3.1.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players by Revenue (2016-2021)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Concentration Ratio
3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2020
3.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Key Players Head office and Area Served
3.6 Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Solution and Service
3.7 Date of Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Breakdown Data by Type
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Size by Type (2016-2021)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Type (2022-2027)

5 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Breakdown Data by Application
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Size by Application (2016-2021)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2016-2027)
6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
6.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021)
6.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027)
6.2.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2027)
6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
6.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021)
6.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027)
6.3.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2027)
6.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
6.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021)
6.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2016-2027)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
7.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021)
7.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027)
7.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2027)
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
7.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021)
7.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027)
7.3.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2027)
7.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
7.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021)
7.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2016-2027)
8.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
8.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
8.3.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region
8.4.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2016-2027)
9.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
9.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2027)
9.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
9.3.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2027)
9.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
9.4.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2016-2027)
10.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
10.2.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
10.3.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
10.4.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.1.4 Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
11.1.5 Stryker Recent Development
11.2 Balt
11.2.1 Balt Company Details
11.2.2 Balt Business Overview
11.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.2.4 Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
11.2.5 Balt Recent Development
11.3 TERUMO
11.3.1 TERUMO Company Details
11.3.2 TERUMO Business Overview
11.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.3.4 TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
11.3.5 TERUMO Recent Development
11.4 MicroPort
11.4.1 MicroPort Company Details
11.4.2 MicroPort Business Overview
11.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.4.4 MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
11.4.5 MicroPort Recent Development
11.5 Acandis
11.5.1 Acandis Company Details
11.5.2 Acandis Business Overview
11.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.5.4 Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
11.5.5 Acandis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stent
Table 3. Key Players of PTA Balloon
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Regions (2016-2021)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Regions (2022-2027)
Table 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Trends
Table 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers
Table 12. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
Table 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Players (2016-2021)
Table 16. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2020)
Table 17. Ranking of Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Solution and Service
Table 21. Date of Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Stryker Company Details
Table 62. Stryker Business Overview
Table 63. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 64. Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021) & (US$ Million)
Table 65. Stryker Recent Development
Table 66. Balt Company Details
Table 67. Balt Business Overview
Table 68. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 69. Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021) & (US$ Million)
Table 70. Balt Recent Development
Table 71. TERUMO Company Details
Table 72. TERUMO Business Overview
Table 73. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 74. TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021) & (US$ Million)
Table 75. TERUMO Recent Development
Table 76. MicroPort Company Details
Table 77. MicroPort Business Overview
Table 78. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 79. MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021) & (US$ Million)
Table 80. MicroPort Recent Development
Table 81. Acandis Company Details
Table 82. Acandis Business Overview
Table 83. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 84. Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021) & (US$ Million)
Table 85. Acandis Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type: 2020 VS 2027
Figure 2. Stent Features
Figure 3. PTA Balloon Features
Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Report Years Considered
Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Regions (2022-2027)
Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Players in 2020
Figure 14. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2020
Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2016-2027)
Figure 20. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2016-2027)
Figure 21. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2016-2027)
Figure 22. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2016-2027)
Figure 26. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2016-2027)
Figure 27. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2016-2027)
Figure 28. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Region (2016-2027)
Figure 38. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2016-2027)
Figure 46. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2016-2027)
Figure 47. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2016-2027)
Figure 48. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2016-2027)
Figure 54. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Stryker Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
Figure 58. Balt Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
Figure 59. TERUMO Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
Figure 60. MicroPort Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
Figure 61. Acandis Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---